Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2007The Journal of Infectious Diseases

Antiretroviral Therapy–Associated Toxicities in the Resource‐Poor World: The Challenge of a Limited Formulary

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRichard A. MurphyUniversity of Southern CaliforniaHSHenry SunpathUniversity of KwaZulu-NatalDKDaniel R. KuritzkesBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Murphy et al. (2007) studied this question.

synapsesocial.com/papers/6ab62dd2bb3fdd31b7449166https://doi.org/10.1086/521112
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Randomized Trial (ISS 902) of Didanosine versus Zidovudine in Previously Untreated Patients with Mildly Symptomatic Human Immunodeficiency Virus Infection1997 · 7 citations
  2. 2Hepatotoxicity Associated With Nevirapine Use2004 · 125 citations
  3. 3Haematological Changes in Adults Receiving a Zidovudine-Containing Haart Regimen in Combination with Cotrimoxazole in Côte D'ivoire2005 · 118 citations
  4. 4Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?2004 · 339 citations
  5. 5Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study2004 · 186 citations